HUMAN FIBROBLAST-DERIVED DERMAL SUBSTITUTE (HFDS) INCREASES DERMAL ANTIOXIDANTS AND IMPROVES REEPITHELIALIZATION OF WOUNDED SKIN EXPLANTS FROM YOUNG AND AGED DONORS

被引：0

作者：

Moor, A. N. ^{[1
,2
]}

Young, C. ^{[3
]}

Wilkins-Port, C. ^{[3
]}

Gould, L. J. ^{[1
,2
]}

机构：

[1] James A Haley Vet Hosp, Tampa, FL 33612 USA

[2] Univ S Florida, Tampa, FL USA

[3] Shire Regenerat Med, San Diego, CA USA

来源：

WOUND REPAIR AND REGENERATION | 2013年 / 21卷 / 02期

关键词：

D O I：

暂无

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：A36 / A36

页数：1

共 28 条

[1] Dermagraft - human fibroblast-derived dermal substitute
Mansbridge, J.
JOURNAL OF ANATOMY, 2006, 209 (04) : 571 - 571
[2] HUMAN FIBROBLAST-DERIVED DERMAL SUBSTITUTE (HFDS*) PROMOTES WOUND HEALING BY BOTH IMMEDIATE AND EXTENDED MECHANISMS
Wilkins-Port, C. E.
Browning, C. S.
Self, C.
Hart, C. E.
Young, C. S.
WOUND REPAIR AND REGENERATION, 2014, 22 (02) : A67 - A67
[3] DIFFERENTIATION OF A HUMAN FIBROBLAST-DERIVED DERMAL SUBSTITUTE (HFDS*) AND CRYOPRESERVED HUMAN SKIN ALLOGRAFT (TS#) FOR PROPERTIES RELATED TO WOUND HEALING
Wilkins-Port, C. E.
Browning, C. S.
Self, C.
Hart, C. E.
Young, C. S.
WOUND REPAIR AND REGENERATION, 2014, 22 (02) : A67 - A67
[4] EVALUATION OF WOUND HEALING EFFECTS OF A LIVING HUMAN FIBROBLAST-DERIVED DERMAL SUBSTITUTE (V-HFDS*), NONVIABLE HUMAN FIBROBLAST-DERIVED DERMAL SUBSTITUTE (NV-HFDS) AND 90:10 POLYGLYCOLIDE-CO-L-LACTIDE (PGLLA#) MESH SCAFFOLD IN A FULL-THICKNESS DERMAL WOUND MODEL IN ATHYMIC RATS
Shah, V. R.
Kadoya, K.
Hart, C. E.
Young, C.
WOUND REPAIR AND REGENERATION, 2014, 22 (02) : A58 - A58
[5] Healing chronic infected foot wounds with human fibroblast-derived dermal substitute and silver dressings
Carson, SN
Pankovich, A
Travis, E
To, D
Rodriguez, A
WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE, 2005, 17 (10): : 282 - 289
[6] Circadian rhythm of autophagy in human dermal fibroblasts derived from young and aged donors
Dong, K.
Pelle, E.
Layman, D.
Yarosh, D. B.
Pernodet, N.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S83 - S83
[7] Treatment of chronic leg ulcers with a human fibroblast-derived dermal substitute: A case series of 114 patients
Hjerppe, A
Hjerppe, M
Autio, V
Raudasoja, R
Vaalasti, A
WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE, 2004, 16 (03): : 97 - 104
[8] EVALUATION OF WOUND HEALING AND BIOCOMPATIBILITY OF HUMAN FIBROBLAST-DERIVED DERMAL SUBSTITUTE (HFDS*) COMBINED WITH AN ANTIMICROBIAL BARRIER SILVER DRESSING (AC#) IN AN ATHYMIC RAT FULL-THICKNESS DERMAL WOUND HEALING MODEL
Shah, V.
Kadoya, K.
Young, C.
WOUND REPAIR AND REGENERATION, 2014, 22 (02) : A58 - A58
[9] Replacement of animal-derived collagen matrix by human fibroblast-derived dermal matrix for human skin equivalent products
El Ghalbzouri, Abdoelwaheb
Commandeur, Suzan
Rietveld, Marion H.
Mulder, Aat A.
Willemze, Rein
BIOMATERIALS, 2009, 30 (01) : 71 - 78
[10] Human Fibroblast-Derived Dermal Substitute: Results from a Treatment Investigational Device Exemption (TIDE) Study in Diabetic Foot Ulcers
Warriner, Robert A., III
Cardinal, Matthew
ADVANCES IN SKIN & WOUND CARE, 2011, 24 (07) : 306 - 311

← 1 2 3 →